$16.16
0.140.87%
At close: -
$16.19
0.030.19%
After Hours: 6:37 PM EDT
ADMA Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ADMA Biologics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $0.15 | $0.13 | 15.4 % |
Q2 | 2024-08-08 | $0.13 | $0.08 | 62.5 % |
Q1 | 2024-05-09 | $0.08 | $0.05 | 60.0 % |
Q4 | 2024-02-28 | $0.04 | $0.02 | 100.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $119.84M | $105.85M | 13.2 % |
Q2 | 2024-08-08 | $107.19M | $86.41M | 24.1 % |
Q1 | 2024-05-09 | $81.88M | $77.27M | 5.96 % |
Q4 | 2024-02-28 | $73.90M | $72.15M | 2.43 % |
ADMA Biologics (ADMA) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $0.15, which beat the estimate of $0.13.
The Actual Revenue was $119.8M, which beat the estimate of $105.8M.
Browse earnings estimates, EPS, and revenue on all stocks.